Drawing from secondments acting as in-house counsel for pharmaceutical manufacturers of various growth stages, Dominick DiSabatino counsels pharmaceutical, biotechnology, cosmetics and medical device companies on business decisions spanning the entire product life cycle, from research and development to product launch and commercialization.
Dominick’s experience covers industry-critical regulatory and compliance concerns, including interactions with health care providers and patients, managed markets and payer strategies, promotional and scientific review committees, privacy matters, and anti-kickback, anti-bribery and anti-corruption. He also advises life sciences clients on matters concerning transparency reporting and disclosures; post-market adverse event and product complaint reporting; recalls, prohibitions, warning letters and Form 483s; environmental hazard regulations; and corporate due diligence. With his background in intellectual property law, Dominick also provides insight on issues related to patents, trademarks, copyrights and trade secrets.
Dominick is dedicated to industry education, teaching CLE courses, authoring publications and speaking at public events and conferences.
Health care today resides at the touchpoint of medicine, technology and law. This reality presents tough questions that require not only an understanding of the laws that regulate the industry but also the underlying technology itself.
Dominick is also committed to pro bono service. He has counseled nonprofit organizations focused on health care integration and optimization and post-incarceration reentry programs. He also represented New York City’s senior citizens in housing disputes and provided First Amendment advice for press operations in Africa.
- George Washington University Law School, 法学博士, with honors
- Bucknell University, 学士
- Admitted Only in